Physician profile
Jill A Augustine
NPI 1548399751
$7,986.16
in general payments reported to CMS, 2019-2025
11 companies · $42.99 in 2025
The $42.99 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $954 · 2022: $3,526 · 2023: $3,057 · 2024: $406 · 2025: $42.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,006 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.78 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,490.11 | 2021-2025 | Lifevest |
| Medtronic, INC. | $2,190.78 | 2021-2025 | Linq II, Micra |
| Astrazeneca Pharmaceuticals Lp | $930.79 | 2021-2024 | Farxiga |
| Abbott Laboratories | $509.56 | 2021-2023 | Cardiomems |
| Novo Nordisk INC | $226.22 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.65 | 2022-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $132.19 | 2023 | |
| United Therapeutics Corporation | $102.00 | 2024 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $98.68 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $97.23 | 2022 | |
| Alexion Pharmaceuticals, INC. | $44.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jill Augustine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.